November Awareness and Appreciation Recap

November was a month dedicated to recognition, education and support across our neurology and neuromedicine communities. We observed National Family Caregivers Month, honoring the essential role of care partners who provide strength, stability and compassionate support for their loved ones. We also recognized Alzheimer’s Awareness Month, joining national efforts to increase understanding of dementia and promote earlier diagnosis, research progress and community resources.

This month also included World Movement Disorders Day, a global moment to elevate awareness of Parkinson’s disease, dystonia, essential tremor and other movement disorders that affect millions worldwide. In addition, we honored Veterans Day, expressing our gratitude to veterans and acknowledging the neurological conditions that disproportionately impact this population, including traumatic brain injury, Parkinson’s disease, ALS and other service-related health concerns.

Together, these observances reflect our continued commitment to advancing care, research and support for every individual and family affected by neurological disease.

December Awareness at Fixel  

This December, the Fixel Institute joins the global community in recognizing the International Day of Persons with Disabilities, a day dedicated to promoting understanding, dignity and inclusion for people living with disabilities worldwide. This observance reinforces our commitment to advancing accessible, patient-centered neurological care and supporting innovations that enhance quality of life for individuals and families affected by complex neurological conditions.

We are proud to stand alongside our patients, caregivers, clinicians and researchers as we continue working toward a world where every person, regardless of ability, has access to the resources, opportunities and support needed to thrive.

December 6th: Season of Hope run

Join the community on December 6 for the annual Tyler’s Hope Season for Hope Run, a 5K/15K event supporting the fight against dystonia and other movement disorders. This fundraiser brings together families, runners and advocates to advance research and improve the lives of those affected. Every step helps move us closer to better treatments and a cure.
Click here to register!

Jan 26-28th: AD+ Think Tank 

The 2026 AD+ Think Tank, Alzheimer's disease with Co-Pathology, will bring together leading experts in neurodegeneration to explore the complex biological relationships between Alzheimer’s disease and co-occurring neuropathologies. Through presentations, discussions and collaborative sessions, the event will highlight emerging research, clinical implications and future directions for diagnosis, treatment and scientific discovery. This gathering serves as a catalyst for innovation and cross-disciplinary partnerships aimed at improving outcomes for patients affected by Alzheimer’s and related neurodegenerative diseases.

Fixel Café is Now Open!

It’s been a long time in the making, and we’re excited to announce the opening of the Fixel Café in the lobby of the Fixel Clinic building! Stop by to meet Terra, the friendly face behind the café, and enjoy a delicious drink or snack. We look forward to this new addition bringing warmth, connection and something tasty to our community.

Research & Technology Innovation Incubator Coming Soon...

The second floor of the Fixel Institute Research & Administration building is being transformed into the Research & Technology Innovation Incubator (RTII). A state-of-the-art hub designed to spark collaboration and accelerate discovery in neurological care.

Renovations will kickoff early 2026! During this time, the second floor will be closed to employees, with restrooms and water fountains available on the first floor only.

We look forward to sharing updates as the RTII takes shape and ushers in a new era of innovation at the Fixel Institute.

Dimitry Davydow named Lauren and Lee Fixel Chair

The Fixel Institute is proud to announce the appointment of Dimitry S. Davydow, MD, MPH, FACLP, to the prestigious Lauren and Lee Fixel Chair, effective October 8, 2025. A nationally recognized psychiatrist and Vice Chair for Clinical Operations in UF’s Department of Psychiatry and Behavioral Sciences, Dr. Davydow brings an exceptional record of clinical leadership, research, mentorship and cross-disciplinary collaboration. His work explores how disrupted brain circuits drive psychiatric symptoms in neurodegenerative disease, and this endowed chair will support his efforts to advance targeted treatments and deepen integration between psychiatry and neurology. The institute honored Dr. Davydow at a recognition reception on October 21 as we celebrated this important milestone and we extend our gratitude to Lauren and Lee Fixel for their transformative generosity.

Dawn Schiehser named Leslie & Michael Okun Rising Star Endowed Professor

The Fixel Institute is proud to announce that Dawn M. Schiehser, Ph.D., an internationally recognized neuropsychologist specializing in movement disorders, has been appointed the Leslie & Michael Okun Rising Star Endowed Professor. Dr. Schiehser joins UF’s Department of Clinical and Health Psychology, where she will advance innovative clinical and translational research focused on the cognitive, psychiatric and behavioral symptoms of neurological disease. Her work will strengthen neuropsychological services across the Fixel Institute’s multidisciplinary programs and help drive new discoveries in Parkinson’s disease, traumatic brain injury and related conditions. This esteemed professorship supports emerging leaders shaping the future of neuroscience, and Dr. Schiehser’s appointment marks an exciting step forward in expanding patient-centered, research-driven neurological care at UF Health.

ALS Center of Excellence Designation

The Fixel Institute has been designated an ALS Center of Excellence, recognizing its comprehensive, patient-centered care and commitment to advancing ALS research.

James Wymer, M.D., Ph.D., shared that the designation “validates the hard work we do at the Fixel Center” and affirms that the ALS Association considers the program among the state’s best. He credits the team’s multidisciplinary approach, integration of research and unwavering focus on whole-person care as key to this achievement.

Dr. Wymer noted that the recognition strengthens the institute’s visibility and supports expanded access to resources and research for patients. “Our team has always been focused on providing the best care,” he said. “ALS patients are the most giving and loving patients, and this honor helps us continue improving care for them and others.”

This milestone marks an important step forward as Fixel continues to grow its ALS services and scientific impact.

2025 Parkinson's Disease Prevention Think Tank

The Fixel Institute partnered with the Parkinson's Foundation and recently hosted the 2025 Parkinson’s Disease Prevention Think Tank, bringing together leading scientists, clinicians, researchers and public health experts from across the country. The event centered on advancing early detection, risk-reduction strategies and innovative approaches that could shift the future of Parkinson’s disease prevention. Through dynamic presentations, collaborative discussions and cross-disciplinary problem-solving, attendees explored emerging science, environmental and genetic risk factors, biomarkers, lifestyle interventions and opportunities for large-scale preventive research. This year’s think tank strengthened national partnerships and reaffirmed the Fixel Institute’s commitment to driving groundbreaking work aimed at delaying, or ultimately preventing, the onset of Parkinson’s disease.

Farewell and congratulations to Dr. Adolfo Ramirez-Zamora

The Fixel Institute extends heartfelt appreciation to Adolfo Ramirez-Zamora, M.D., as he concludes his tenure at UF and steps into his new role as Chair of Neurology at the University of Louisville.

Dr. Ramirez-Zamora has been a transformative leader at the Fixel Institute, serving as Professor of Neurology, Division Chief of Movement Disorders, and Program Director. His expertise in complex movement disorders, neuromodulation and deep brain stimulation has elevated our clinical care, research and national reputation.

A respected clinician, scientist and mentor, he has contributed significantly to advancing movement disorders research, strengthening multidisciplinary care and shaping the next generation of specialists. His leadership roles with the Parkinson’s Foundation, AAN and major study groups further reflect his dedication to improving the lives of people affected by neurological disease.

While we will miss his presence and guidance, we are proud to celebrate this exciting next step in his career. We are deeply grateful for his years of service and wish him continued success in Kentucky.